While these findings highlight the importance of sTREM2 as a biomarker in AD, it remains unclear whether the elevated sTREM2 levels reflect an overall increase in TREM2 expression due to inflammation, selective enhancement of proteolytic processing, or altered splicing of TREM2. The gene discussed is TREM2; the disease is Alzheimer disease.